Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 4/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.44 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26239074 | 0.85 | KCNH2 (0.44) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL26238906 | 0.84 | KCNH2 (0.50) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL4029855 | 0.76 | PRMT5 (0.58) | PRCPKCNH2HRH3 | |
| SCHEMBL26238905 | 0.74 | PRCP (0.58) | PRCPSLC18A3 | |
| SCHEMBL25389373 | 0.73 | PRCP (0.48) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL19370816 | 0.73 | KCNH2 (0.43) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL27498941 | 0.72 | KCNH2 (0.60) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL24029313 | 0.71 | OPRM1 (0.47) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL26239083 | 0.70 | PRCP (0.45) | PRCPKCNH2HRH3OPRM1SLC18A3 | |
| SCHEMBL15840473 | 0.70 | ADAMTS5 (0.58) | PRCPKCNH2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250280861-A1 | SWEETENER COMPOSITIONS | FIRMENICH INCORPORATED (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4472947-A1 | SWEETENER COMPOSITIONS | Firmenich Incorporated (US) | 2024-12-11 | — | — | EP | disclosed |
| WO-2023172415-A1 | SWEETENER COMPOSITIONS | FIRMENICH INCORPORATED (US) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023172415-A1 | SWEETENER COMPOSITIONS | FIRMENICH INCORPORATED (US) | 2023-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250280861-A1 | SWEETENER COMPOSITIONS | GPR119, TAS2R50, TAS2R30 | PRCP 1490/4885KCNH2 3794/4885HRH3 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.